- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Australian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
U.S. Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
76 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RGSRegeneus | AU$0.088 | 3.5% | -29.6% | AU$27.0m | n/a | PE9.8x | n/a | n/a | ||
| SPLStarpharma Holdings | AU$1.11 | -3.5% | -23.4% | AU$451.4m | n/a | PS210.2x | n/a | n/a | ||
| ATHAlterity Therapeutics | AU$0.02 | 0% | -45.9% | AU$48.1m | n/a | PS11.1x | n/a | n/a | ||
| CGBCann Global | AU$0.003 | 20.0% | -62.5% | AU$19.0m | n/a | PS13x | n/a | n/a | ||
| MVPMedical Developments International | AU$4.45 | -5.3% | -38.3% | AU$317.2m | AU$4.90 | PS12.6x | E84.0% | 0% | ||
| BITBiotron | AU$0.082 | -5.7% | 1.2% | AU$57.6m | n/a | PS39.4x | n/a | n/a | ||
| NSBNeuroScientific Biopharmaceuticals | AU$0.33 | -7.0% | 37.5% | AU$47.3m | n/a | PS49.4x | n/a | n/a | ||
| ACWActinogen Medical | AU$0.13 | -13.3% | 490.9% | AU$231.3m | n/a | PS117.1x | n/a | n/a | ||
| IVXInvion | AU$0.02 | 0% | 110.5% | AU$128.3m | n/a | PS55.6x | n/a | n/a | ||
| ADOAnteoTech | AU$0.37 | 15.6% | 236.4% | AU$730.4m | n/a | PS319x | n/a | n/a | ||
| PAAPharmAust | AU$0.11 | -4.3% | 10.0% | AU$34.9m | n/a | PS9.5x | n/a | n/a | ||
| IMUImugene | AU$0.34 | -4.3% | 191.3% | AU$1.9b | n/a | PS270.2x | E-12.7% | n/a | ||
| GSSGenetic Signatures | AU$1.44 | -17.2% | -27.3% | AU$206.1m | AU$2.20 | PE117.5x | E-33.6% | n/a | ||
| AGNArgenica Therapeutics | AU$0.86 | -8.5% | n/a | AU$62.9m | n/a | PS212.9x | n/a | n/a | ||
| IDTIDT Australia | AU$0.22 | -5.4% | 20.8% | AU$52.1m | n/a | PE24.8x | n/a | 0% | ||
| NOXNoxopharm | AU$0.39 | -16.1% | -33.3% | AU$114.0m | n/a | PS20.3x | n/a | n/a | ||
| CSLCSL | AU$264.52 | -4.2% | -3.7% | AU$126.6b | AU$322.10 | PE38.4x | E8.5% | 1.1% | ||
| RCERecce Pharmaceuticals | AU$1.28 | 6.7% | 23.1% | AU$222.4m | n/a | PS135.9x | n/a | n/a | ||
| AVEAvecho Biotechnology | AU$0.015 | -6.3% | -34.8% | AU$27.6m | n/a | PS62.5x | n/a | n/a | ||
| MDCMedlab Clinical | AU$0.14 | 0% | -57.6% | AU$47.9m | n/a | PS10.9x | E37.2% | n/a | ||
| CHMChimeric Therapeutics | AU$0.24 | -4.0% | -33.3% | AU$80.5m | AU$1.19 | PB3.2x | E54.6% | n/a | ||
| IMMImmutep | AU$0.42 | -7.7% | 3.7% | AU$358.7m | AU$1.17 | PS92.9x | E40.5% | n/a | ||
| NC6Nanollose | AU$0.095 | -3.1% | -47.2% | AU$14.1m | n/a | PS44x | n/a | n/a | ||
| VLSVita Life Sciences | AU$2.00 | 0.8% | 108.3% | AU$110.4m | n/a | PE16.4x | n/a | 2.7% |